GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers

BACKGROUND: Immunotherapy using immune checkpoint inhibitors (ICIs), such as antibody of programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) has showed as a promising treatment for esophageal squamous cell carcinoma (ESCC), but resistance is unavoidable. This study aimed to find more immune-...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Donghui, Yuan, Ligong, Li, Feng, Wang, Shuaibo, Mao, Yousheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976371/
https://www.ncbi.nlm.nih.gov/pubmed/35365175
http://dx.doi.org/10.1186/s12920-022-01223-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976371/
https://www.ncbi.nlm.nih.gov/pubmed/35365175
http://dx.doi.org/10.1186/s12920-022-01223-x

Ejemplares similares